Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and Angiogenesis, Pathologic

staurosporine has been researched along with Angiogenesis, Pathologic in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Acero, N; Añorbe, L; Braña, MF; Domínguez, G; Mitjans, F; Muñoz-Mingarro, D; Piulats, J1
Assefnia, S; Brown, ML; Byers, SW; Dakshanamurthy, S; Issa, NT; Madhavan, S; Peters, OJ; Seshasayee, A; Uren, A1
Gong, G; Kong, X; Wen, Z; Zheng, Y1
Fiedler, W; Wellbrock, J1
Honda, Y; Kemmochi, S; Miyamoto, N; Oh, H; Ohashi, H; Ojima, T; Sato, Y; Suganami, E; Suzuma, I; Suzuma, K; Takagi, H; Uemura, A; Watanabe, D1
Daida, H; Kashiwakura, Y; Kumon, H; Kusumi, N; Nagai, A; Nasu, Y; Sasano, T; Shimada, T; Tamayose, K; Watanabe, M1
Arbiser, JL; Bhandarkar, S; Cance, WG; Funa, NS; Kurenova, EV; Reddy, K; Welsh, M; Yang, L1
Kan, M; Kobayashi, K; Rhim, JS; Seki, M; Seon, BK; Shitara, K; Toi, M; Umezawa, K1
Figg, WD; Krüger, EA1
Ashino, H; Kanayasu, T; Morita, I; Murota, S; Nakamura, O; Oikawa, T; Shimamura, M1

Reviews

1 review(s) available for staurosporine and Angiogenesis, Pathologic

ArticleYear
Clinical experience with antiangiogenic therapy in leukemia.
    Current cancer drug targets, 2011, Volume: 11, Issue:9

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Clinical Trials as Topic; Humans; Indoles; Lenalidomide; Leukemia; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Quinazolines; Sorafenib; Staurosporine; Sunitinib; Thalidomide; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A

2011

Other Studies

9 other study(ies) available for staurosporine and Angiogenesis, Pathologic

ArticleYear
Synthesis and biological evaluation of novel indolocarbazoles with anti-angiogenic activity.
    European journal of medicinal chemistry, 2012, Volume: 48

    Topics: Angiogenesis Inhibitors; Animals; Capillaries; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Humans; Laminin; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neovascularization, Pathologic; Proteoglycans; Spectrophotometry, Infrared; Staurosporine

2012
Predicting new indications for approved drugs using a proteochemometric method.
    Journal of medicinal chemistry, 2012, Aug-09, Volume: 55, Issue:15

    Topics: Animals; Antineoplastic Agents; Antirheumatic Agents; Cadherins; Celecoxib; Cell Line, Tumor; Crystallography, X-Ray; Databases, Factual; Drug Discovery; Drug Repositioning; Drugs, Investigational; Human Umbilical Vein Endothelial Cells; Humans; Mebendazole; Mice; Models, Molecular; Neovascularization, Pathologic; Pharmaceutical Preparations; Protein Binding; Protein Conformation; Proteins; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor Receptor-2

2012
Anti-angiogenesis Function of Ononin via Suppressing the MEK/Erk Signaling Pathway.
    Journal of natural products, 2021, 06-25, Volume: 84, Issue:6

    Topics: Angiogenesis Inhibitors; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoflavones; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2

2021
Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization.
    The American journal of pathology, 2004, Volume: 164, Issue:5

    Topics: Adenoviridae; Angiopoietin-2; Animals; Blotting, Northern; Blotting, Western; Butadienes; Carbazoles; Cattle; Cell Division; Disease Models, Animal; DNA; Enzyme Inhibitors; Flavonoids; Genes, Dominant; Humans; Hypoxia; Indoles; Maleimides; Mice; Models, Biological; Neovascularization, Pathologic; Neuropilin-1; Nitriles; Phosphorylation; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Reperfusion Injury; Retina; RNA, Messenger; Staurosporine; Time Factors; Transcription Factors; Up-Regulation; Vascular Endothelial Growth Factor A

2004
Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth.
    Human gene therapy, 2005, Volume: 16, Issue:6

    Topics: Animals; Apoptosis; Cell Proliferation; Dependovirus; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genetic Therapy; Genetic Vectors; Humans; Injections, Intralesional; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Prostate; Prostatic Neoplasms; Serpins; Staurosporine; Survival Rate; Transduction, Genetic; Tumor Cells, Cultured

2005
Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
    The Journal of investigative dermatology, 2008, Volume: 128, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Endothelial Cells; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Hemangiosarcoma; In Vitro Techniques; Lignans; Mice; Mice, Nude; Mutagenesis; Neoplasm Transplantation; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Staurosporine

2008
Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines.
    International journal of oncology, 2000, Volume: 17, Issue:3

    Topics: Angiogenesis Inhibitors; Cell Division; Cell Line, Transformed; Cell Transformation, Viral; Cyclohexanes; Cytokines; Drug Screening Assays, Antitumor; Endothelium, Vascular; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, ras; Genistein; Humans; Lactones; Macrolides; Neoplasm Proteins; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Oncogene Protein p21(ras); Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Repressor Proteins; Sesquiterpenes; Signal Transduction; Staurosporine; Umbilical Veins

2000
Protein binding alters the activity of suramin, carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:7

    Topics: Alkaloids; Angiogenesis Inhibitors; Animals; Aorta, Thoracic; Biological Assay; Blood Proteins; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Neovascularization, Pathologic; Protein Binding; Rats; Rats, Sprague-Dawley; Staurosporine; Suramin; Triazoles

2001
Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.
    The Journal of antibiotics, 1992, Volume: 45, Issue:7

    Topics: Alkaloids; Animals; Carotid Arteries; Cattle; Cells, Cultured; Chick Embryo; Dose-Response Relationship, Drug; Endothelium; Neovascularization, Pathologic; Protein Kinase Inhibitors; Staurosporine

1992